Revolutionizing treatment for neurological conditions with 3D printed surgical implants

FHS
May 6, 2024
6:54 am

Clever bio-inks that sit inside the human body and restore damaged neurons could cure a whole swathe of diseases in the next 20 years: conditions that have baffled scientists and clinicians for centuries.

Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Atirmociclib

The revenue for Atirmociclib is expected to reach an annual total of $388 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue

July 2, 2024

Patent Filed by Incyte Corp for Cancer Treatment Compound

Share this article According to GlobalData’s company profile on Incyte, Peptide pharmacophores was a key innovation area identified from patents. Incyte‘s grant share as of

April 4, 2024

Ferroptosis regulation of GLS2 as a potential therapeutic strategy against liver diseases

A new editorial paper was published in Oncotarget’s Volume 14 on October 19, 2023, entitled, “GLS2 shapes ferroptosis in hepatocellular carcinoma.”

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.